Cooper Companies (COO)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of The Cooper Companies (COO)
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Key Insights
Critical company metrics and information
Share Price
$98.70Market Cap
$19.66 BillionTotal Outstanding Shares
199.16 Million SharesTotal Employees
15,000Dividend
$0.03 Per Share BiannuallyIPO Date
December 6, 1983SIC Description
Ophthalmic GoodsHomepage
https://www.coopercos.com
Historical Stock Splits
If you bought 1 share of COO before February 20, 2024, you'd have 4 shares today.
Execution Date | Split Amount |
---|---|
February 20, 2024 | 4-for-1 |
Cash Flow Statement
August 1, 2023 to July 31, 2024
Metric | Value |
---|---|
Net Cash Flow From Investing Activities | $-683.80 Million |
Exchange Gains/Losses | $400000.00 |
Net Cash Flow From Financing Activities | $61.10 Million |
Net Cash Flow From Investing Activities, Continuing | $-683.80 Million |
Net Cash Flow From Operating Activities, Continuing | $615.40 Million |
Net Cash Flow From Operating Activities | $615.40 Million |
Net Cash Flow From Financing Activities, Continuing | $61.10 Million |
Net Cash Flow, Continuing | $-7.30 Million |
Net Cash Flow | $-7.70 Million |
Income Statement
August 1, 2023 to July 31, 2024
Metric | Value |
---|---|
Basic Earnings Per Share | $6.26 |
Selling, General, and Administrative Expenses | $1.53 Billion |
Research and Development | $154.10 Million |
Income/Loss From Continuing Operations Before Tax | $520.10 Million |
Net Income/Loss Available To Common Stockholders, Basic | $359.30 Million |
Diluted Average Shares | $50.90 Million |
Gross Profit | $2.52 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Income/Loss From Continuing Operations After Tax | $359.30 Million |
Net Income/Loss Attributable To Parent | $359.30 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Revenues | $3.80 Billion |
Other Operating Expenses | $197.50 Million |
Cost Of Revenue | $1.28 Billion |
Benefits Costs and Expenses | $3.28 Billion |
Diluted Earnings Per Share | $6.23 |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Income Tax Expense/Benefit | $160.80 Million |
Operating Income/Loss | $643.00 Million |
Operating Expenses | $1.88 Billion |
Basic Average Shares | $50.50 Million |
Costs And Expenses | $3.28 Billion |
Net Income/Loss | $359.30 Million |
Balance Sheet
August 1, 2023 to July 31, 2024
Metric | Value |
---|---|
Liabilities | $4.18 Billion |
Inventory | $779.30 Million |
Equity | $7.93 Billion |
Other Current Liabilities | $591.00 Million |
Intangible Assets | $1.79 Billion |
Equity Attributable To Parent | $7.92 Billion |
Other Non-current Assets | $6.65 Billion |
Other Current Assets | $1.15 Billion |
Current Assets | $1.93 Billion |
Fixed Assets | $1.75 Billion |
Equity Attributable To Noncontrolling Interest | $200000.00 |
Noncurrent Assets | $10.18 Billion |
Current Liabilities | $969.50 Million |
Accounts Payable | $222.00 Million |
Assets | $12.11 Billion |
Wages | $156.50 Million |
Noncurrent Liabilities | $3.21 Billion |
Liabilities And Equity | $12.11 Billion |
Historical Dividends
Current dividend: $0.03 Per Share Biannually
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Jul 12, 2023 | Aug 11, 2023 | Jul 27, 2023 | $0.03 | Biannually |
Dec 14, 2022 | Feb 10, 2023 | Jan 23, 2023 | $0.03 | Biannually |
Jul 13, 2022 | Aug 11, 2022 | Jul 27, 2022 | $0.03 | Biannually |
Dec 8, 2021 | Feb 9, 2022 | Jan 21, 2022 | $0.03 | Biannually |
Jul 14, 2021 | Aug 11, 2021 | Jul 27, 2021 | $0.03 | Biannually |
Jan 7, 2021 | Feb 9, 2021 | Jan 22, 2021 | $0.03 | Biannually |
Jul 9, 2020 | Aug 7, 2020 | Jul 23, 2020 | $0.03 | Biannually |
Jan 7, 2020 | Feb 10, 2020 | Jan 23, 2020 | $0.03 | Biannually |
Jul 10, 2019 | Aug 7, 2019 | Jul 23, 2019 | $0.03 | Biannually |
Jan 7, 2019 | Feb 8, 2019 | Jan 22, 2019 | $0.03 | Biannually |
Jul 12, 2018 | Aug 7, 2018 | Jul 23, 2018 | $0.03 | Biannually |
Jan 4, 2018 | Feb 9, 2018 | Jan 23, 2018 | $0.03 | Biannually |
Jul 6, 2017 | Aug 7, 2017 | Jul 21, 2017 | $0.03 | Biannually |
Jan 5, 2017 | Feb 9, 2017 | Jan 23, 2017 | $0.03 | Biannually |
Jul 7, 2016 | Aug 5, 2016 | Jul 22, 2016 | $0.03 | Biannually |
Jan 7, 2016 | Feb 9, 2016 | Jan 22, 2016 | $0.03 | Biannually |
Jul 9, 2015 | Aug 6, 2015 | Jul 24, 2015 | $0.03 | Biannually |
Jan 8, 2015 | Feb 9, 2015 | Jan 23, 2015 | $0.03 | Biannually |
Jul 10, 2014 | Aug 6, 2014 | Jul 24, 2014 | $0.03 | Biannually |
Jan 8, 2014 | Feb 7, 2014 | Jan 24, 2014 | $0.03 | Biannually |
Jul 11, 2013 | Aug 6, 2013 | Jul 24, 2013 | $0.03 | Biannually |
Jan 8, 2013 | Feb 7, 2013 | Jan 25, 2013 | $0.03 | Biannually |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
â“’ 2024 Financhle. All Rights Reserved.